Jose-Alberto Palma

Jose-Alberto Palma

Auto-generated profile, based on publicly available information

Jose-Alberto Palma

Department of Neurology New York University Grossman School of Medicine New York NY USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2022 in Movement Disorders
Verified
Journal Article
Open access
GWGregor K. Wenning
Gregor K. Wenning
ISIva Stankovic
Iva Stankovic
LVLuca Vignatelli
Luca Vignatelli
AFAlessandra Fanciulli
Alessandra Fanciulli
GCGiovanna Calandra‐Buonaura
Giovanna Calandra‐Buonaura
HKHoracio Kaufmann
Horacio Kaufmann
Background: The second consensus criteria for the diagnosis of multiple system atrophy (MSA) are widely recognized as the reference standard for clinical research, but lack sensitivity to diagnose the disease at early stages.Objective: To develop novel Movement Disorder Society (MDS) criteria for MSA diagnosis using an evidence‐based and consensus‐based methodology.Methods: We identified shortcomings of the second consensus criteria for MSA diagnosis and conducted a systematic literature review to answer predefined questions on clinical presentation and diagnostic tools relevant for MSA diagnosis. The criteria were developed and later optimized using two Delphi rounds within the MSA Criteria Revision Task Force, a survey for MDS membership, and a virtual Consensus Conference.Results: The criteria for neuropathologically established MSA remain unchanged. For a clinical MSA diagnosis a new category of clinically established MSA is introduced, aiming for maximum specificity with acceptable sensitivity. A category of clinically probable MSA is defined to enhance sensitivity while maintaining specificity. A research category of possible prodromal MSA is designed to capture patients in the earliest stages when symptoms and signs are present, but do not meet the threshold for clinically established or clinically probable MSA. Brain magnetic resonance imaging markers suggestive of MSA are required for the diagnosis of clinically established MSA. The number of research biomarkers that support all clinical diagnostic categories will likely grow.Conclusions: This set of MDS MSA diagnostic criteria aims at improving the diagnostic accuracy, particularly in early disease stages. It requires validation in a prospective clinical and a clinicopathological study. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

17 January 2017 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
HKHoracio Kaufmann
Horacio Kaufmann
LNLucy Norcliffe‐Kaufmann
Lucy Norcliffe‐Kaufmann
JPJose‐Alberto Palma
Jose‐Alberto Palma
IBItalo Biaggioni
Italo Biaggioni
PLPhillip A. Low
Phillip A. Low
OCon behalf of the Autonomic Disorders Consortium
on behalf of the Autonomic Disorders Consortium

25 August 2022 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
WPWerner Poewe
Werner Poewe
ISIva Stankovic
Iva Stankovic
GHGlenda Halliday
Glenda Halliday
WMWassilios Meissner
Wassilios Meissner
GWGregor K. Wenning
Gregor K. Wenning
HKHoracio Kaufmann
Horacio Kaufmann

5 February 2018 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
LNLucy Norcliffe‐Kaufmann
Lucy Norcliffe‐Kaufmann
HKHoracio Kaufmann
Horacio Kaufmann
JPJose‐Alberto Palma
Jose‐Alberto Palma
CSCyndya A. Shibao
Cyndya A. Shibao
IBItalo Biaggioni
Italo Biaggioni
ACAutonomic Disorders Consortium
Autonomic Disorders Consortium

5 March 2018 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
JPJose‐Alberto Palma
Jose‐Alberto Palma
HKHoracio Kaufmann
Horacio Kaufmann

15 July 2014 in Neurology
Verified
Journal Article
Closed access
PDF file
JPJose-Alberto Palma
Jose-Alberto Palma
EBEduardo E. Benarroch
Eduardo E. Benarroch